DATE:

Government expenditure on diabetes medicines increased from almost $130 million in 2000 to about $500 million in 2013. In 2013, the highest expenditure was on insulins, followed by fixed dose combinations and DPP-4 inhibitors, while the lower cost metformin and sulfonylureas were the most commonly prescribed … ................
................